nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—Asthma aggravated—Ramipril—type 1 diabetes mellitus	0.109	0.169	CcSEcCtD
Buprenorphine—Depressed mood—Ramipril—type 1 diabetes mellitus	0.028	0.0437	CcSEcCtD
Buprenorphine—Balance disorder—Ramipril—type 1 diabetes mellitus	0.0229	0.0357	CcSEcCtD
Buprenorphine—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.0145	0.0225	CcSEcCtD
Buprenorphine—Drug interaction—Ramipril—type 1 diabetes mellitus	0.0135	0.0211	CcSEcCtD
Buprenorphine—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.0105	0.0164	CcSEcCtD
Buprenorphine—Libido decreased—Ramipril—type 1 diabetes mellitus	0.0098	0.0153	CcSEcCtD
Buprenorphine—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00902	0.0141	CcSEcCtD
Buprenorphine—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.0083	0.0129	CcSEcCtD
Buprenorphine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.0083	0.0129	CcSEcCtD
Buprenorphine—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00821	0.0128	CcSEcCtD
Buprenorphine—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00819	0.0128	CcSEcCtD
Buprenorphine—Influenza—Ramipril—type 1 diabetes mellitus	0.00786	0.0123	CcSEcCtD
Buprenorphine—Asthma—Ramipril—type 1 diabetes mellitus	0.00786	0.0123	CcSEcCtD
Buprenorphine—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00786	0.0123	CcSEcCtD
Buprenorphine—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00773	0.0121	CcSEcCtD
Buprenorphine—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00765	0.0119	CcSEcCtD
Buprenorphine—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00756	0.0118	CcSEcCtD
Buprenorphine—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00753	0.0117	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.0073	0.0114	CcSEcCtD
Buprenorphine—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00681	0.0106	CcSEcCtD
Buprenorphine—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00681	0.0106	CcSEcCtD
Buprenorphine—Sweating—Ramipril—type 1 diabetes mellitus	0.00672	0.0105	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00663	0.0103	CcSEcCtD
Buprenorphine—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00657	0.0102	CcSEcCtD
Buprenorphine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.0062	0.00966	CcSEcCtD
Buprenorphine—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00618	0.00964	CcSEcCtD
Buprenorphine—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00606	0.00945	CcSEcCtD
Buprenorphine—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00586	0.00914	CcSEcCtD
Buprenorphine—Flushing—Ramipril—type 1 diabetes mellitus	0.00584	0.0091	CcSEcCtD
Buprenorphine—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00568	0.00886	CcSEcCtD
Buprenorphine—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00567	0.00884	CcSEcCtD
Buprenorphine—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00551	0.00859	CcSEcCtD
Buprenorphine—Erythema—Ramipril—type 1 diabetes mellitus	0.00547	0.00854	CcSEcCtD
Buprenorphine—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00547	0.00854	CcSEcCtD
Buprenorphine—Tension—Ramipril—type 1 diabetes mellitus	0.00537	0.00838	CcSEcCtD
Buprenorphine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00536	0.00836	CcSEcCtD
Buprenorphine—Nervousness—Ramipril—type 1 diabetes mellitus	0.00532	0.00829	CcSEcCtD
Buprenorphine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00526	0.00821	CcSEcCtD
Buprenorphine—Tremor—Ramipril—type 1 diabetes mellitus	0.00513	0.008	CcSEcCtD
Buprenorphine—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00508	0.00792	CcSEcCtD
Buprenorphine—Agitation—Ramipril—type 1 diabetes mellitus	0.00503	0.00785	CcSEcCtD
Buprenorphine—Angioedema—Ramipril—type 1 diabetes mellitus	0.005	0.0078	CcSEcCtD
Buprenorphine—Malaise—Ramipril—type 1 diabetes mellitus	0.00494	0.0077	CcSEcCtD
Buprenorphine—Vertigo—Ramipril—type 1 diabetes mellitus	0.00492	0.00767	CcSEcCtD
Buprenorphine—Syncope—Ramipril—type 1 diabetes mellitus	0.00491	0.00766	CcSEcCtD
Buprenorphine—Palpitations—Ramipril—type 1 diabetes mellitus	0.00484	0.00754	CcSEcCtD
Buprenorphine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00481	0.0075	CcSEcCtD
Buprenorphine—Cough—Ramipril—type 1 diabetes mellitus	0.00478	0.00745	CcSEcCtD
Buprenorphine—Convulsion—Ramipril—type 1 diabetes mellitus	0.00474	0.0074	CcSEcCtD
Buprenorphine—Chest pain—Ramipril—type 1 diabetes mellitus	0.00466	0.00727	CcSEcCtD
Buprenorphine—Myalgia—Ramipril—type 1 diabetes mellitus	0.00466	0.00727	CcSEcCtD
Buprenorphine—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00466	0.00727	CcSEcCtD
Buprenorphine—Anxiety—Ramipril—type 1 diabetes mellitus	0.00464	0.00724	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00463	0.00722	CcSEcCtD
Buprenorphine—Discomfort—Ramipril—type 1 diabetes mellitus	0.0046	0.00718	CcSEcCtD
Buprenorphine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00456	0.00711	CcSEcCtD
Buprenorphine—Confusional state—Ramipril—type 1 diabetes mellitus	0.00451	0.00703	CcSEcCtD
Buprenorphine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00447	0.00697	CcSEcCtD
Buprenorphine—Oedema—Ramipril—type 1 diabetes mellitus	0.00447	0.00697	CcSEcCtD
Buprenorphine—Shock—Ramipril—type 1 diabetes mellitus	0.0044	0.00685	CcSEcCtD
Buprenorphine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00438	0.00683	CcSEcCtD
Buprenorphine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00436	0.0068	CcSEcCtD
Buprenorphine—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00434	0.00677	CcSEcCtD
Buprenorphine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00432	0.00674	CcSEcCtD
Buprenorphine—Anorexia—Ramipril—type 1 diabetes mellitus	0.00426	0.00664	CcSEcCtD
Buprenorphine—Hypotension—Ramipril—type 1 diabetes mellitus	0.00417	0.00651	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00407	0.00635	CcSEcCtD
Buprenorphine—Insomnia—Ramipril—type 1 diabetes mellitus	0.00404	0.0063	CcSEcCtD
Buprenorphine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00401	0.00626	CcSEcCtD
Buprenorphine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00398	0.00621	CcSEcCtD
Buprenorphine—Somnolence—Ramipril—type 1 diabetes mellitus	0.00397	0.00619	CcSEcCtD
Buprenorphine—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00393	0.00613	CcSEcCtD
Buprenorphine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00388	0.00606	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00386	0.00602	CcSEcCtD
Buprenorphine—Fatigue—Ramipril—type 1 diabetes mellitus	0.00385	0.00601	CcSEcCtD
Buprenorphine—Constipation—Ramipril—type 1 diabetes mellitus	0.00382	0.00596	CcSEcCtD
Buprenorphine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00368	0.00574	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00365	0.0057	CcSEcCtD
Buprenorphine—Urticaria—Ramipril—type 1 diabetes mellitus	0.00355	0.00554	CcSEcCtD
Buprenorphine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00353	0.00551	CcSEcCtD
Buprenorphine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00353	0.00551	CcSEcCtD
Buprenorphine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00329	0.00513	CcSEcCtD
Buprenorphine—Asthenia—Ramipril—type 1 diabetes mellitus	0.00321	0.005	CcSEcCtD
Buprenorphine—Pruritus—Ramipril—type 1 diabetes mellitus	0.00316	0.00493	CcSEcCtD
Buprenorphine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00306	0.00477	CcSEcCtD
Buprenorphine—Dizziness—Ramipril—type 1 diabetes mellitus	0.00295	0.00461	CcSEcCtD
Buprenorphine—Vomiting—Ramipril—type 1 diabetes mellitus	0.00284	0.00443	CcSEcCtD
Buprenorphine—Rash—Ramipril—type 1 diabetes mellitus	0.00282	0.00439	CcSEcCtD
Buprenorphine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00281	0.00439	CcSEcCtD
Buprenorphine—Headache—Ramipril—type 1 diabetes mellitus	0.0028	0.00436	CcSEcCtD
Buprenorphine—Nausea—Ramipril—type 1 diabetes mellitus	0.00265	0.00414	CcSEcCtD
Buprenorphine—CYP3A5—Metabolism—ABCC8—type 1 diabetes mellitus	0.000166	0.000464	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000166	0.000464	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000166	0.000463	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—G6PC2—type 1 diabetes mellitus	0.000166	0.000463	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000165	0.000461	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000165	0.000461	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000165	0.000461	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000165	0.000459	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000164	0.000458	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000158	0.000441	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	0.000158	0.00044	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000156	0.000435	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ITPR3—type 1 diabetes mellitus	0.000155	0.000432	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000155	0.000431	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	0.000154	0.000429	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ITPR3—type 1 diabetes mellitus	0.000154	0.000428	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000149	0.000416	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	0.000148	0.000413	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000147	0.000411	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000147	0.00041	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—HBA1—type 1 diabetes mellitus	0.000146	0.000406	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000145	0.000405	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	0.000145	0.000404	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000145	0.000404	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—APOC3—type 1 diabetes mellitus	0.000145	0.000404	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000145	0.000404	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—HBA1—type 1 diabetes mellitus	0.000145	0.000403	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000145	0.000403	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000144	0.000403	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000144	0.000402	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ABCC8—type 1 diabetes mellitus	0.000144	0.000402	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	0.000144	0.000401	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—APOC3—type 1 diabetes mellitus	0.000144	0.0004	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000144	0.0004	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CAT—type 1 diabetes mellitus	0.000143	0.000399	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000142	0.000397	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000142	0.000396	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GSTT1—type 1 diabetes mellitus	0.000141	0.000393	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ITPR3—type 1 diabetes mellitus	0.000141	0.000392	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000141	0.000392	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00014	0.000391	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00014	0.000389	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00014	0.000389	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000138	0.000384	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000138	0.000384	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000137	0.000383	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000136	0.00038	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	0.000135	0.000377	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000134	0.000373	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GCG—type 1 diabetes mellitus	0.000134	0.000372	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—HBA1—type 1 diabetes mellitus	0.000132	0.000369	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000132	0.000367	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—APOC3—type 1 diabetes mellitus	0.000132	0.000367	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000131	0.000367	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GSTT1—type 1 diabetes mellitus	0.000129	0.00036	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000129	0.00036	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	0.000129	0.000358	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000126	0.00035	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000125	0.000349	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000125	0.000348	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000125	0.000348	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000124	0.000347	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	0.000123	0.000343	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000123	0.000342	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000122	0.00034	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000121	0.000338	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000121	0.000337	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000121	0.000336	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00012	0.000335	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	0.000118	0.00033	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	0.000117	0.000327	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000116	0.000322	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000115	0.00032	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000114	0.000318	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000114	0.000317	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GCG—type 1 diabetes mellitus	0.000113	0.000316	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CAT—type 1 diabetes mellitus	0.000113	0.000315	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GCG—type 1 diabetes mellitus	0.000112	0.000313	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ITPR3—type 1 diabetes mellitus	0.000111	0.000309	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.00011	0.000308	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.00011	0.000306	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000109	0.000305	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000109	0.000305	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000108	0.000302	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000107	0.000297	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000105	0.000294	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000105	0.000294	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000105	0.000293	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000105	0.000293	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—HBA1—type 1 diabetes mellitus	0.000104	0.000291	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000104	0.000291	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOC3—type 1 diabetes mellitus	0.000104	0.000289	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GCG—type 1 diabetes mellitus	0.000103	0.000287	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000102	0.000285	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GSTT1—type 1 diabetes mellitus	0.000102	0.000284	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000102	0.000284	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000102	0.000283	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000101	0.000281	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.0001	0.00028	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	0.0001	0.000279	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.0001	0.000279	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	9.92e-05	0.000277	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ITPR3—type 1 diabetes mellitus	9.61e-05	0.000268	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CAT—type 1 diabetes mellitus	9.6e-05	0.000268	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CAT—type 1 diabetes mellitus	9.51e-05	0.000265	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.5e-05	0.000265	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—INS—type 1 diabetes mellitus	9.5e-05	0.000265	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	9.49e-05	0.000264	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	9.35e-05	0.000261	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.35e-05	0.000261	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.29e-05	0.000259	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	9.27e-05	0.000258	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.25e-05	0.000258	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.21e-05	0.000257	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.14e-05	0.000255	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	9.05e-05	0.000252	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	8.99e-05	0.000251	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	8.92e-05	0.000249	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	8.91e-05	0.000248	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	8.83e-05	0.000246	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	8.77e-05	0.000244	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CAT—type 1 diabetes mellitus	8.72e-05	0.000243	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ALB—type 1 diabetes mellitus	8.71e-05	0.000243	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	8.58e-05	0.000239	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.51e-05	0.000237	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL6—type 1 diabetes mellitus	8.48e-05	0.000236	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.45e-05	0.000236	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	8.38e-05	0.000233	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—NOS3—type 1 diabetes mellitus	8.33e-05	0.000232	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—INS—type 1 diabetes mellitus	8.28e-05	0.000231	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	8.14e-05	0.000227	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GCG—type 1 diabetes mellitus	8.12e-05	0.000226	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	8.08e-05	0.000225	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.03e-05	0.000224	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	8.03e-05	0.000224	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.01e-05	0.000223	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.97e-05	0.000222	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	7.92e-05	0.000221	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.9e-05	0.00022	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	7.89e-05	0.00022	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	7.88e-05	0.00022	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	7.88e-05	0.00022	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	7.83e-05	0.000218	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	7.82e-05	0.000218	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.79e-05	0.000217	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	7.73e-05	0.000216	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.73e-05	0.000215	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	7.69e-05	0.000214	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CD80—type 1 diabetes mellitus	7.69e-05	0.000214	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—INS—type 1 diabetes mellitus	7.51e-05	0.000209	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	7.43e-05	0.000207	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.4e-05	0.000206	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	7.38e-05	0.000206	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	7.36e-05	0.000205	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	7.32e-05	0.000204	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.27e-05	0.000203	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.27e-05	0.000203	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—INS—type 1 diabetes mellitus	7.26e-05	0.000203	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	7.25e-05	0.000202	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	7.19e-05	0.0002	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	7.04e-05	0.000196	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.03e-05	0.000196	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.99e-05	0.000195	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ALB—type 1 diabetes mellitus	6.88e-05	0.000192	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CAT—type 1 diabetes mellitus	6.88e-05	0.000192	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	6.74e-05	0.000188	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	6.69e-05	0.000186	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	6.62e-05	0.000185	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—NOS3—type 1 diabetes mellitus	6.58e-05	0.000184	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	6.5e-05	0.000181	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.49e-05	0.000181	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—INS—type 1 diabetes mellitus	6.37e-05	0.000178	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.37e-05	0.000178	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—INS—type 1 diabetes mellitus	6.32e-05	0.000176	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	6.29e-05	0.000175	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	6.28e-05	0.000175	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	6.25e-05	0.000174	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.17e-05	0.000172	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	6.16e-05	0.000172	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	6.14e-05	0.000171	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—INS—type 1 diabetes mellitus	6.14e-05	0.000171	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	6.13e-05	0.000171	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.13e-05	0.000171	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	6.11e-05	0.00017	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	5.96e-05	0.000166	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.94e-05	0.000166	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.91e-05	0.000165	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ALB—type 1 diabetes mellitus	5.84e-05	0.000163	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ALB—type 1 diabetes mellitus	5.79e-05	0.000161	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—INS—type 1 diabetes mellitus	5.79e-05	0.000161	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	5.78e-05	0.000161	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	5.73e-05	0.00016	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.66e-05	0.000158	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—NOS3—type 1 diabetes mellitus	5.59e-05	0.000156	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—NOS3—type 1 diabetes mellitus	5.54e-05	0.000154	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.49e-05	0.000153	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.41e-05	0.000151	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2—type 1 diabetes mellitus	5.4e-05	0.000151	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.38e-05	0.00015	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.37e-05	0.00015	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	5.32e-05	0.000148	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ALB—type 1 diabetes mellitus	5.31e-05	0.000148	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	5.19e-05	0.000145	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.18e-05	0.000144	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	5.16e-05	0.000144	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NOS3—type 1 diabetes mellitus	5.08e-05	0.000141	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	4.89e-05	0.000136	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	4.89e-05	0.000136	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	4.86e-05	0.000135	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	4.85e-05	0.000135	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	4.83e-05	0.000135	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	4.74e-05	0.000132	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.71e-05	0.000131	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.57e-05	0.000127	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	4.56e-05	0.000127	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.56e-05	0.000127	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.54e-05	0.000127	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.54e-05	0.000127	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	4.19e-05	0.000117	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	4.14e-05	0.000115	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.13e-05	0.000115	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	4e-05	0.000112	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	3.95e-05	0.00011	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.84e-05	0.000107	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.78e-05	0.000105	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	3.62e-05	0.000101	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.62e-05	0.000101	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	3.53e-05	9.84e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.49e-05	9.73e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	3.47e-05	9.67e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.44e-05	9.6e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	3.25e-05	9.05e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	3.24e-05	9.02e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	3.22e-05	8.97e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	3.2e-05	8.91e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.17e-05	8.85e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	3.16e-05	8.8e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	3.09e-05	8.63e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	3.02e-05	8.42e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	2.98e-05	8.3e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	2.95e-05	8.22e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.85e-05	7.93e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	2.82e-05	7.87e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	2.75e-05	7.67e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.68e-05	7.48e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	2.52e-05	7.03e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	2.41e-05	6.72e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.12e-05	5.92e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.95e-05	5.42e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.86e-05	5.19e-05	CbGpPWpGaD
